Download PDF
Thromb Haemost 1990; 64(01): 177-178
DOI: 10.1055/s-0038-1647277
Letter to the Editor
Schattauer GmbH Stuttgart

Decreased Free Protein S Levels in Polycythemia Vera

M Zoppi
The Central Haematology Laboratory University of Bern, Inselspital CH-3010 Bern, Switzerland
,
M Furlan
The Central Haematology Laboratory University of Bern, Inselspital CH-3010 Bern, Switzerland
,
G Brun del Re
The Central Haematology Laboratory University of Bern, Inselspital CH-3010 Bern, Switzerland
,
W Wuillemin
The Central Haematology Laboratory University of Bern, Inselspital CH-3010 Bern, Switzerland
,
B Lämmle
The Central Haematology Laboratory University of Bern, Inselspital CH-3010 Bern, Switzerland
› Author Affiliations
Further Information

Publication History

Received 20 December 1989

Accepted after revision 19 March 1990

Publication Date:
25 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984; 64: 1-12
    PubMedGoogle Scholar
  • 2 Grossi A, Rosseti S, Vannucci AM, Rafanelli D, Rossi FerriniP. Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients. Clin Lab Haematol 1988; 10: 167-175
    CrossrefPubMedGoogle Scholar
  • 3 Pearson TC. Haematocrit, blood viscosity, cerebral blood flow, and vascular occlusion. In: Clinical Aspects of Blood Viscosity and Cell Deformability Lowe G DO. (ed) Springer Verlag; Berlin: 1981: 97-107
  • 4 Barbui T, Cortelazzo SS, Viero P, Bassan R, Dini E, Semeraro N. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function. Eur J Cancer Clin Oncol 1983; 19: 1593-1599
    CrossrefPubMedGoogle Scholar
  • 5 Tartaglia AP, Goldberg JD, Silverstein MN, Dresch C, Tatarsky I, Pisciotta AV, Faguet G, Rosenthal D, Conjalka M, Donovan PB, Berk PD, Wassermann LR. Aspirin and persantine do not prevent thrombotic complications in patients with polycythemia vera treated with phlebotomy. Blood 1981; 58 (Suppl. 01) 240
    PubMedGoogle Scholar
  • 6 Thommen D, Buhrfeind E, Felix R, Sulzer I, Furlan M, Lämmle B. Hämostaseparameter bei 55 Patienten mit venösen und/oder arteriel-len Thromboembolien. Schweiz Med Wochenschr 1989; 119: 493-499
    PubMedGoogle Scholar
  • 7 Berlin NI. Diagnosis and classification of the polycythemias. Semin Hematol 1975; 12: 339-351
    PubMedGoogle Scholar
  • 8 Martinoli JL, Stocker K. Fast functional protein C assay using Protac, a novel protein C activator. Thromb Res 1986; 43: 253-264
    CrossrefPubMedGoogle Scholar
  • 9 Schwarz HP, Heeb MJ, Lämmle B, Berrettini M, Griffin JH. Quantitative immunoblotting of plasma and platelet protein S. Thromb Haemostas 1986; 56: 382-386
    PubMedGoogle Scholar
  • 10 Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1352
    CrossrefPubMedGoogle Scholar
  • 11 Conlan MG, Haire WD. Low protein S in essential thrombocythemia with thrombosis. Am J Hematol 1989; 32: 88-93
    CrossrefPubMedGoogle Scholar